Magnetar Financial LLC Nevro Corp Transaction History

Magnetar Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$40.85 - $77.67 $2.47 Million - $4.7 Million	60,514 New	60,514 $2.65 Million
Q1 2022 May 16, 2022	SELL	$59.95 - $92.06 $537,271 - $825,041	-8,962 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $726,549 - $1.09 Million	8,962 New	8,962 $727,000
Q3 2021 Nov 12, 2021	SELL	$101.99 - $166.36 $319,432 - $521,039	-3,132 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$141.6 - $179.06 $1.15 Million - $1.46 Million	-8,143 Reduced 72.22%	3,132 $519,000
Q1 2021 May 14, 2021	BUY	$132.81 - $182.18 $1.25 Million - $1.72 Million	9,449 Added 517.47%	11,275 $1.57 Million
Q4 2020 Feb 12, 2021	BUY	$138.17 - $184.34 $252,298 - $336,604	1,826 New	1,826 $316,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.